Stemgenics is a groundbreaking brand that specializes in converting mature skin cells into stem cells. Their innovative Nanotherapeutics for IN VIVO Reprogramming offers a revolutionary approach to cell reprogramming and control of cell fate. The brand is led by Dr.

Andranik Andrew Aprikyan, Founder, Chief Executive Officer, and Chief Scientific Officer. With over 30 years of research and teaching experience, Dr. Aprikyan's recent discoveries have paved the way for Stemgenics' multi-functionalized cell-penetrant nanoparticle reprogramming platform technologies.

In addition to Dr. Aprikyan, Stemgenics boasts a team of distinguished scientific advisors and consultants who are experts in stem cell therapy, pluripotent stem cells, mature cell reprogramming, cardiovascular biology, and cardiac physiology. Together, they contribute to the development of Stemgenics' cutting-edge products and services.

Stemgenics offers a range of advantages and benefits, including targeted control of cell fate and functions. They are dedicated to advancing the field of regenerative medicine and providing effective solutions for a variety of diseases and conditions. Choose Stemgenics for their expertise, groundbreaking technology, and commitment to improving the field of stem cell research.

Contact them today to learn more about their innovative products and services